Liquidators of biotech startup in talks over stake in drug firm

Synthase Biotech's trademarked enzyme Aloxsyn had been shown to improve the ability of cows to conceive. (Image: Unsplash)

Riley Kennedy

Thu, 23 Jan 2025

Liquidators of a collapsed animal-breeding startup are in talks about its stake in another drug development company.Set up in 2015, Synthase Biotech had developed a plant-based enzyme that stopped fats from going rancid.The Waikato-based company, which leased premises at AgResearch’s Ruakura campus in Hamilton, initially targeted artificial insemination for the global dairy industry and undertook its first capital raise of $800,000 in 2016.However, it collapsed in June last year after failing to find enough commercial contracts for its pr...

Subscribe to BusinessDesk

Stay informed on business, government and financial developments across New Zealand.

Deeply researched, twice-edited and fact-checked news
Annual subscribers also receive a complimentary subscription to The Wall Street Journal
Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers

You can cancel anytime with two clicks, an email or a phone call.
Find out more.

We are serious about journalism.

Already a Subscriber ? Sign in here.

Name {{ registerForm.errors.get('name') }}

Email address {{ registerForm.errors.get('email') }}

Phone Number {{ registerForm.errors.get('phone') }}

Job Title {{ registerForm.errors.get('title') }}

Password Minimum password length of 8 characters.
Require at least one upper and lowercase, numeric, and special character. {{ registerForm.errors.get('password') }}

Repeat password {{ registerForm.errors.get('password_confirmation') }}

We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.

Credit Card

Cardholder's name

{{ __(plans[index].name) | capitalize }} {{ plans[index].attributes.old_price | currency }} {{ plans[index].price | currency }}

All subscriptions auto renew but are easy to cancel.

I Accept The Terms Of Service

{{ registerForm.errors.get('terms') }}

Tax: {{ taxAmount(selectedPlan) | currency }}

Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}

Policy

EPA head quits with fast-track changes

The latest fast-track reforms go far beyond supermarket resource consenting.

Pattrick Smellie and Dileepa Fonseka 5:00am

Markets

Sharesies founders sell down

Global tech investor Rahul Mehta appears on the register for the first time.

Pattrick Smellie 5:00am

Self promotion

BusinessDesk appoints Jaime Lyth

BusinessDesk continues to grow.

Staff reporters 5:00am

Sponsored

Health insurance proving a valuable negotiating tool for Kiwi businesses

More employers see health insurance as key to staff wellbeing.

Moneyfit

Sponsored

Move-in ready offices: How business are rethinking workspace

Businesses want agility – and office space is evolving fast

Sponsored by Precinct Properties

More Primary Sector

Primary Sector

Less than 10% of Provincial Growth Fund loans repaid

Of nearly $366m paid out in loans, just over $34m has been repaid.

Michael Neilson 04 Nov 2025

Primary Sector

Mammoth application for Santana gold mine

A 9,400-page submission targets what is said to be NZ's largest gold find in 40 years.

Pattrick Smellie 03 Nov 2025

Primary Sector

Rising volumes push Port of Tauranga profit outlook higher

Port of Tauranga expects its full-year net profit after tax to fall somewhere between $137 million and $147m.The NZX-listed port company’s container volumes increased 9% to 319,649 TEUs in the first three months to Sept 30.Total trade increased 5.9% in volume compared to the same...

Staff reporters 31 Oct 2025

Primary Sector

AgriZeroNZ invests $1.7m in Australian cattle IVF platform

AgriZeroNZ has invested A$1.5 million (NZ$1.7m) into Queensland biotech company Nbyro, which aims for faster breeding of more emissions-efficient livestock.The public-private joint venture was the co-leader in a wider funding round for Nbyro. The stake is AgriZeroNZ’s 10th equity...

Staff reporters 31 Oct 2025

Liquidators of biotech startup in talks over stake in drug firm

More Primary Sector

Your company has a subscription

Team